Item 5.02 Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain
On October 5, 2021, Douglas M. VanOort, the former Chief Executive Officer of
NeoGenomics, Inc. (the "Company") and currently the Company's Executive Chairman
and Chairman of the Board of Directors (the "Board") of the Company, notified
the Board of his voluntary decision to retire from the Company and that in
connection with his retirement he was tendering his resignation as Executive
Chairman and Chairman of the Board of the Company, effective October 7, 2021.
Mr. VanOort will remain as a director on the Board but plans to retire as a
member of the Board before the end of the year as the Board concludes an ongoing
search process. Mr. VanOort's decision to retire and resign as Executive
Chairman and Chairman of the Board was not the result of any dispute or
disagreement with the Company, the Company's management or the Board on any
matter relating to the operations, policies or practices of the Company.
On October 5, 2021, the Board acknowledged Mr. VanOort's decision to retire,
accepted Mr. VanOort's resignation as Executive Chairman and Chairman of the
Board of the Company effective October 7, 2021, and appointed Lynn A. Tetrault,
the Company's Lead Independent Director, as the non-executive Chair of the
Board, effective October 7, 2021. Ms. Tetrault has served as Lead Independent
Director of the Board since July 2020 and has been on the Board since June 2015.
The Board also approved Ms. Tetrault to receive an additional quarterly fee of
$15,625, and an equity grant in the amount of $50,000 for serving as Chair of
Following the effective date of his resignation as Executive Chairman and
Chairman of the Board, Mr. VanOort's compensation as a director is consistent
with the compensation of other directors as described in the Company's Proxy
Statement on Schedule 14A for the Company's 2021 Annual Meeting of Stockholders,
which was filed with the SEC on April 15, 2021.
Item 7.01 Regulation FD Disclosure.
On October 12, 2021, the Company issued a press release announcing Mr. VanOort's
retirement as the Company's Executive Chairman and Chairman of the Board of
Directors and the appointment of Lynn Tetrault as the new Non-executive Chair of
the Board, the entire text of which is attached hereto as Exhibit 99.1 and is
incorporated by reference herein.
Item 9.01 Financial Statements and Exhibits.
Exhibit No. Description
99.1 Press Release of NeoGenomics, Inc. dated October 1 2 , 2021.
104 Cover Page Interactive Data File (embedded within the Inline XBRL
© Edgar Online, source Glimpses